Investors

 
AccessClosure is proud to be working with Onset Ventures, Three Arch Partners, Integral Capital Partners and New Leaf Ventures, four of the premier venture capital organizations in the medical technology industry.

onset ONSET Ventures specializes in providing an ideal mix of start-up, follow-on, and intellectual capital to entrepreneurs and early-stage technology ventures, to help transform world-class ideas into sustainable and valuable businesses. The firm has backed nearly 100 companies since 1984 and now has more than $700 million under management. ONSET Ventures focuses exclusively on information and medical technology-based start-ups, and has a long history of successful ventures in each of these sectors.
www.onset.com

three_arch

Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as capital. Three Arch Partners has helped create, build, and fund more than fifty healthcare companies. The investment focus is on opportunities in medical devices and healthcare services, as well as biotechnology and information technology. The partnership manages $1 billion in capital. We are actively seeking new investments in seed, early stage, and development stage companies.
www.threearchpartners.com

icp_logo

Integral Capital Partners operates a family of partnerships that invests in expansion-stage private and growth-stage public companies in the information technology and life sciences industries. Since its inception in 1991, Integral has organized and managed seven funds and currently manages over $900 million in assets. With our insights and network of business development resources, Integral offers the promise of value-added investing to portfolio companies. Mr. Brian Stanksy serves as an observer on the company’s board of directors.
www.icp.com

new_leaf

New Leaf Venture Partners is a leader in healthcare technology venture investing. Our investment professionals bring a unique blend of technological, clinical, and operational experience to our investments. We work closely with our entrepreneurs to help build successful portfolio companies. We focus primarily on later stage biopharmaceutical products, early stage medical devices, and laboratory infrastructure technologies. New Leaf currently manages over $800 million of assets. We manage the entire healthcare technology portfolio of the Sprout Group, one of the oldest U.S. venture capital fund groups, and we are actively investing a $310 million healthcare technology-dedicated fund, New Leaf Ventures I, L.P.
www.nlvpartners.com